• AstraZeneca coronavirus vaccine clinical trial paused

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    Patient wearing mask gets COVID vaccine injection

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    According to an article in Stat, AstraZeneca (NYSE: AZN) has paused the U.S. clinical trial of its coronavirus vaccine, AZD1222, after a serious possible adverse event arose in a patient enrolled in a clinical trial testing AZD122 in the U.K.

    At this point, the nature of the adverse event is not known, and it isn’t clear whether it was caused by AZD122. The company is “working to expedite the review of the single event to minimize any potential impact on the trial timeline,” according to Stat. The participant is expected to recover. 

    In addition to the 30,000-participant U.S. study announced last week, AstraZeneca is also running clinical trials in the U.K., Brazil, and South Africa. The company plans to start studies in Japan and Russia as well. All told, the studies will enroll up to 50,000 participants globally.

    It isn’t publicly known exactly how many patients have received AZD1222, but investors can get some clues from Moderna (NASDAQ: MRNA), which had enrolled 21,411 participants in its late-stage coronavirus vaccine clinical trial as of Friday. Meanwhile, vaccine collaborators Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) had enrolled 25,189 participants as of an update on Monday.

    With that many people enrolled in coronavirus clinical trials, it’s highly likely that one of the participants would develop a serious illness unrelated to the vaccination. Of course, proving that it’s unrelated could be challenging and might only be possible by testing AZD122 on more participants. If the adverse event only occurs in one out of 50,000 participants, it’s either unrelated or a side effect with such a low incidence level that it’s a tolerable issue.

    Shares of AstraZeneca were down 6.5% at 6:40 p.m. EDT in after-hours trading.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Brian Orelli, PhD has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post AstraZeneca coronavirus vaccine clinical trial paused appeared first on Motley Fool Australia.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    from Motley Fool Australia https://ift.tt/2GM0061

  • Tech share prices are down but not out. When should you buy?

    abstract technology chart graphic

    It was bound to happen sooner or later.

    Like Icarus flying too high too fast only to have the sun melt the wax holding his wings together, the share market correction we’re witnessing right now was inevitable.

    Only the timing was in doubt. And we’re happy to leave trying to time the share market highs and lows to those with a penchant for gambling and far deeper pockets than ours.

    Unlike Icarus, though, global share markets aren’t in a death spiral. The wings – if we can stretch the analogy – are still firmly in place.

    Namely: record low interest rates for the foreseeable future; trillions of dollars in new fiscal stimulus projects in the pipeline across the developed world; plenty more quantitative easing (QE) ahead from the central banks; cashed up retail and institutional investors still waiting on the sidelines (Warren Buffett’s Berkshire Hathaway alone was sitting on some US$150 billion (AU$208 billion) in cash at the end of June). And let’s not forget the host of quality listed companies creating real world value with their businesses.

    Nonetheless, the blistering pace of the technology led share market rebound since March 23 was due for a pullback.

    The share price retrace we had to have

    The NASDAQ-100 Index (NASDAQ: NDX) – containing the biggest 100 tech-oriented shares of the broader Nasdaq Composite Index (NASDAQ: .IXIC) – gained 77% from 23 March through to its all-time highs last Wednesday, 2 September.

    Following yesterday’s (overnight Aussie time) 4.8% loss, the Nasdaq-100 is now down almost 11% since that high. Some of the index’s biggest companies, the same ones who helped drive the 77% gains in less than 6 months, are now pulling it lower.

    The Apple Inc. (NASDAQ: AAPL) share price fell 6.7% yesterday. It’s now 16% below its record highs from last Tuesday, 1 September. That’s seen its market cap drop below the much touted US$2 trillion mark.

    The Tesla Inc (NASDAQ: TSLA) share price has fared even worse, shedding a gut-wrenching 21% yesterday. Its now down 34% from it 31 August all-time highs.

    It’s a similar story here in Australia 

    The S&P/ASX All Technology Index (ASX: XTX) tracks 50 of Australia’s leading and emerging technology shares. On 25 August, XTX had gained a whopping 116% from the 23 March low. Since that high it’s down 10%.

    Like the Nasdaq 100, XTX is being pulled lower by some of the same big names that drove it higher.

    Buy now, pay later star Afterpay Ltd‘s (ASX: APT) share price rocketed an astounding 939% from 23 March through 25 August. Since then the share price is down 23%.

    But Afterpay has nothing on its smaller rival Sezzle Inc (ASX: SZL). Sezzle’s share price gained 2,965% from 23 March through its record high on 28 August. Since then the share price is down 40%.

    Now let’s put these daunting losses into some perspective.

    Putting the correction in perspective

    Investors who piled into shares, particularly tech shares, over the past 2 weeks will certainly be feeling the burn.

    Which is a handy reminder of why we Fools recommend dollar cost-averaging (DCA), and not investing all your funds in one go. This helps you to diversify your investment funds across time as well as across a broader basket of shares, cash, bonds and perhaps an allocation to precious metals.

    But getting back to perspective, it’s important to take a step back to see the bigger picture, which gives us a good indication of how things may unfold in the longer-term going forward.

    So here’s the bigger picture, sticking with the 4 shares we’ve highlighted today.

    Year-to-date Sezzle’s share price is up 315%, Afterpay’s share price is up 137%, Tesla’s share price is up 284% and Apple’s share price is up 50%. And that’s from 2 January, mind you, not the 23 March lows following the COVID-19 market rout.

    With that said, is today a good day to buy these and other tech shares that are currently still falling? Probably not. But that time is coming again, likely quite soon. And when it does you won’t want to miss out on the next big share price booms.

    What the market veterans are saying about the current selloff

    Tom Essaye, is a former Merrill Lynch trader and founder of The Sevens Report newsletter. He sounds a note of caution for the short term (as quoted by Bloomberg):

    Some froth has come off the market which is a good thing, but keep in mind that we still remain well over levels that could be considered ‘fair value’ in stocks. And while the outlook for stocks remains generally constructive long term, there’s a lot more downside in this market if we get any major disappointments.

    Peter Chatwell, head of multi-asset strategy at Mizuho International Plc. adds, “The path of least resistance for the market may well be to test the downside. Ultimately, if there is more selloff, I suspect real money investors will take the opportunity to buy the dip.”

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Apple and Tesla. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. recommends Sezzle Inc. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool Australia has recommended Apple and Sezzle Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Tech share prices are down but not out. When should you buy? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3bFLJmx

  • ASX 200 down 2.4%: Afterpay (ASX:APT) and Oil Search (ASX:OSH) sinking lower

    Young man looking afraid representing scared BNPL shares investor

    At lunch on Wednesday the S&P/ASX 200 Index (ASX: XJO) has given back all of yesterday’s gains and more. The benchmark index is currently down a disappointing 2.4% to 5,865.3 points.

    Here’s what has been happening on the market today:

    Tech shares crash lower.

    It has been a difficult day of trade for Australian tech shares such as Afterpay Ltd (ASX: APT) and Appen Ltd (ASX: APX). These two tech stars are down over 4% at the time of writing following another selloff on the tech-heavy Nasdaq index overnight. The Nasdaq crashed 4.1% lower amid further profit taking from investors. The S&P/ASX All Technology Index (ASX: XTX) is down 3.3% at lunch.

    Energy shares tumble.

    It has been an equally difficult day for energy producers such as Oil Search Limited (ASX: OSH) and Santos Ltd (ASX: STO). Investors have been selling their shares after oil prices crashed lower overnight on demand concerns. According to Bloomberg, the WTI crude oil price sank 7.3% lower to US$36.88 a barrel and the Brent crude oil price dropped 5% to US$39.87 a barrel.

    Gold Road half year results.

    The Gold Road Resources Ltd (ASX: GOR) share price is dropping lower following the release of its half year results. For the six-month period ending 30 June, Gold Road produced 131,460 ounces of gold at an all-in sustaining cost of $1,186 per ounce. This ultimately led to the gold miner delivering earnings before interest, tax, depreciation and amortisation (EBITDA) of $61 million. Which compares favourably to a $23 million loss a year earlier.

    Best and worst ASX 200 shares.

    The best performer on the ASX 200 on Wednesday has been the Nufarm Limited (ASX: NUF) share price with a 3% gain. This follows a broker upgrade by Morgans earlier this week. The worst performer has been the Megaport Ltd (ASX: MP1) share price with a 7% decline. Its shares have been caught up in the tech selloff today.

    These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends MEGAPORT FPO. The Motley Fool Australia owns shares of AFTERPAY T FPO and Appen Ltd. The Motley Fool Australia has recommended MEGAPORT FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post ASX 200 down 2.4%: Afterpay (ASX:APT) and Oil Search (ASX:OSH) sinking lower appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3mbE9Fl

  • Brainchip (ASX:BRN) share price jumps 15% after ASX query

    stylised image of exploding cloud coming out of neck of man's suit representing exploding Brainchip share price

    Today Brainchip Holdings Ltd (ASX: BRN) shares are up 15.07% at the time of writing to 84 cents. At one stage in early trade, the Brainchip share price had jumped more than 30% to 97 cents before a pullback. The rally came after the company’s share price soared 30.36% yesterday. 

    The movement in the Brainchip share price yesterday prompted an ASX query or ‘speeding ticket’ requesting if any information that had not yet been announced to the market could be affecting the share price.

    How did Brainchip respond to the ASX query?

    Brainchip Holdings stated that its was not aware of any information that had not yet been announced to the market that could be affecting its share price. It stated “BRN is not aware of any matter that would have effected the recent trading in its securities”.

    Why is the Brainchip share price soaring?

    As we speculated in an article yesterday, it is possible that the Brainchip share price is moving as a result of good news the company released last week. This included a partnership with an American technology company, VORAGO, to supply NASA with its product. Additionally, Brainchip was added to the S&P ASX All Technology Index (ASX: XTX) last week.

    It is also possible that more buyers are newly becoming aware of Brainchip’s offering and would like to add it to their portfolios. It is a unique company, offering computer chips that work in a way similiar to the human brain, so it may be seen by investors to have potential, which has been reflected in its recent deal.

    Additionally, it is conceivable that there is information Brainchip does not yet know which could be affecting the share price. For example, there could be another entity buying up shares that has not yet reported it to the market. Buyers could also be speculating that Brainchip may have future value as an acquisition target.

    What does Brainchip do?

    Brainchip has developed a processing technology named Akida. According to the company, this technology works in a way that mimics the human brain. It can learn new information through experiences without needing to undergo complete retraining and can process data without needing to send it to a data centre for processing. Additionally, the technology has applications for processing visual data, audio data, smell and movement.

    About the Brainchip share price

    The Brainchip share price is up 2,700% since its 52-week low of 3 cents and 1580% since the beginning of the year. The company’s shares are up 2000% since this time last year.

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor Chris Chitty has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Brainchip (ASX:BRN) share price jumps 15% after ASX query appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3m6y6BB

  • Why BrainChip, Codan, IPH, & Nufarm shares are climbing higher today

    asx growth shares

    In late morning trade the S&P/ASX 200 Index (ASX: XJO) has followed the lead of U.S. markets and is sinking lower. At the time of writing the benchmark index is down 2% to 5,885.8 points.

    Four shares that have defied the selloff and pushed higher are listed below. Here’s why they are climbing higher today:

    The BrainChip Holdings Ltd (ASX: BRN) share price is up 14% to 83 cents. Investors continue to buy the artificial intelligence technology company’s shares after it announced a collaboration with VORAGO Technologies at the start of the month. This collaboration  intends to support a Phase 1 NASA program for a neuromorphic processor that meets spaceflight requirements. Today’s gain means BrainChip now has a market capitalisation of over $1.25 billion. Given its limited cash balance, I suspect the company may take advantage of its remarkable share price rise with a capital raising in the near future.

    The Codan Limited (ASX: CDA) share price is up 1% to $10.98 after announcing a major new contract win. This contract is with a large African government to supply tactical communications equipment. Management advised that the contract has a value in the order of US$10 million and includes the supply of Sentry-HTM radios and accessories. It expects this order to be delivered in the second half of FY 2021.

    The IPH Ltd (ASX: IPH) share price has climbed over 2% to $6.80. This is despite there being no news out of the intellectual property services company. However, late last month analysts at Goldman Sachs slapped a buy rating and $8.90 price target on the company’s shares. Some investors may believe it is a bargain buy and one to snap up during the volatility.

    The Nufarm Limited (ASX: NUF) share price is up 3% to $4.25. This is the second day in a row of solid gains for the agricultural chemicals company. The catalyst for this appears to be a broker note out of Morgans this week. Its analysts upgraded Nufarm’s shares to an add rating with an improved price target of $4.85. While it expects a soft FY 2020 result later this month, its analysts suspect that this could be the bottom of the cycle.

    These 3 stocks could be the next big movers in 2020

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Why BrainChip, Codan, IPH, & Nufarm shares are climbing higher today appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/337VtSU

  • What are the odds that Tom Waterhouse makes a great investor?

    racing, horse racing, melbourne cup, winning

    Did you see the news?

    Apparently Tom Waterhouse – yes, that Tom Waterhouse – has gone from bookie, to racing tipster and now wants to start a funds management business.

    Cue much guffawing.

    What does Tom Waterhouse know about stocks?

    How could he possibly be a fund manager?

    Hahahaha!

    And yet…

    I’m no fan of bookies.

    Or racing tipsters.

    Gambing on horse races is a zero-sum game.

    If I win, you lose.

    Actually, it’s worse than that.

    If I win, you lose more, because the house takes its cut, too.

    And unfortunately, there are more than a few people addicted to the punt, and for whom gambling is the cause of much unhappiness, poverty and breakdown.

    And yet…

    The simplistic ‘What would an ex-bookie know about stocks’ is, well, simplistic.

    I have no idea what Tom Waterhouse knows – or doesn’t know – about investing.

    Maybe he’s just looking to parlay his name recognition into a new field.

    Maybe he’ll be terrible at it.

    Maybe he’ll employ others to do the hard work.

    Or maybe he’ll be great.

    Time will tell (and, based on what he was quoted as saying in The Australian yesterday, he’s going to give himself time to earn a track record before putting out his shingle, so he should get credit for that).

    Now, here’s what’s supposed to come next.

    As someone in the investment community, I’m supposed to point out the difference between investing and gambling.

    I’m supposed to say ‘gambling’ with a sneer, clearly letting you know that as an investor, I’m superior in almost every way.

    See, I’m not one of them. I’m one of the good guys.

    But man, there are few things I dislike more than arrogance and smug superiority.

    Especially when it’s not warranted!

    Let me introduce you to one of the best investors in the last half-century.

    His name is Charlie Munger, and he’s Warren Buffett’s right hand man.

    Not only is he a billionaire and a polymath, he’s about as close as it gets to investing royalty.

    Tell ’em what you said, Charlie:

    “We look for a horse with one chance in two of winning and which pays you three to one. You’re looking for a mispriced gamble. That’s what investing is.”

    Well, that’s inconvenient for the ‘investing isn’t gambling’ crowd, huh?

    To be clear, though, what those sneering investors are doing is playing on our preconceptions of those words.

    If someone says “taking a gamble”, we assume they mean “doing something that probably won’t work”.

    When they say “that’s gambling”, they mean “good luck, loser!”

    And maybe that’s fair enough.

    To be sure, the outcomes from – and let’s put those terms aside for a minute – buying and holding shares in quality companies are likely to be better than trying to earn a positive return from a horse race where the outcome is less than zero-sum, after allowing for the house’s take.

    Or, put more simply: History suggests that owning shares is more profitable than playing roulette, blackjack or trying to pick a winner in the 6th at Moonee Valley.

    So, yes, I’d rather people invest in shares than get on the punt.

    But that’s not to say they’re mutually exclusive pastimes.

    Indeed, as Munger points out, both are an exercise in probability.

    More specifically, in risk and return.

    That ‘sure thing’ that got beaten on the weekend? It’s the equivalent of the ‘can’t lose’ blue chip stock your broker recommended that, well, lost.

    The rank outsider that paid 30-to-1? Meet Afterpay, whose shares went up 10-fold after the market lows of late March, and that were up 30-fold in three short years.

    And yes, the 100-to-1 long shot shares more than a little in common with that biotech hopeful or luckless gold explorer that never seems to deliver.

    But good investing shares a lot in common with professional gambling.

    Both require a thorough understanding and assessment of the odds: the risk and potential return.

    Both require a diversified portfolio – of companies or bets – in the full knowledge that some of them will go badly.

    Frankly, the professional gambler is more an investor than the novice day-trader who believes they can beat the market.

    The professional gambler is more an investor than the bloke who buys stuff because their mate suggested it, because it’s going up, or because everyone is talking about it on some free internet forum.

    I hope that makes you uncomfortable. Not because I’m telling you that you’re wrong, per se, but because I hope it leads you to reassess how you invest.

    The aim of investing isn’t to find ‘sure things’.

    No, not because that’d be bad, but rather because it isn’t possible.

    There are no ‘sure things’ – in investing or anywhere else (setting aside death and taxes, that is!).

    But rather because the investor’s job is to try to get a handle on the risk they’re taking, as well as the return they’re being offered.

    If you were offered a 1% return, you’d better hope the investment is about as risk free as they come!

    If you were offered 80%, you should assume there is a very, very high chance of doing your dough.

    But if you were offered, as Charlie Munger suggests, a 50% chance of a 3-to-1 payout, you should take it.

    But first, remember that a horse with a one-in-two chance of winning will actually lose half the time! 

    Munger would be the first to say you shouldn’t put all of your eggs in that one basket.

    What he didn’t say – but those who know Munger’s work would safely suggest he meant – was that he wouldn’t want just one horse, nor a single bet. 

    Munger would want a heap of those mispriced bets. Because he knows that as long as he’s calculated the odds successfully, the average return from a collection of similar bets will be very, very good.

    I have no idea whether or not Tom Waterhouse will be a good investor.

    But what I expect is that years of working as a bookie, and being part of a racing family, should have endowed him with a very good understanding of risk and return.

    There are worse ways to learn something that many ‘investors’ take many years to learn, or never learn at all.

    Fool on.

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor Scott Phillips has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post What are the odds that Tom Waterhouse makes a great investor? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3k269cC

  • Codan (ASX:CDA) share price charges higher on major new contract win

    shares higher, growth shares

    The Codan Limited (ASX: CDA) share price is pushing higher on Wednesday following the release of a positive announcement.

    In morning trade the electronics products company’s shares are up over 2% to $11.07. This compares to a 1.9% decline by the S&P/ASX 200 Index (ASX: XJO).

    This latest gain means the Codan share price is up an impressive 52% since the start of the year. $7.29

    Why is the Codan share price pushing higher today?

    Investors have been buying Codan shares this morning after it announced a major new contract win for its Codan Communications business.

    The Codan Communications business designs and manufactures mission critical communications equipment for global military and public safety applications. These solutions allow users to save lives, enhance security, and support peacekeeping activities across the globe.

    According to today’s announcement, Codan Communications has won a contract with a large African government to supply tactical communications equipment.

    Management advised that the contract has a value in the order of US$10 million and includes the supply of Sentry-HTM radios and accessories. It expects this order to be delivered in the second half of FY 2021.

    It commented: “This is a significant contract for Codan, as it reinforces our strength in providing such equipment to the African market and enhances our strategy to successfully penetrate the security and military sector globally.”

    The government customer intends to deploy Sentry-HTM radios for national security purposes in military operations in a country-wide program. It notes that the contract is a one-off purchase, and there are no material conditions that are required to be satisfied prior to delivery.

    Management also advised that the customer has an investment-grade credit rating with a stable outlook. Nevertheless, given the current economic environment, its longstanding policy of mitigating credit risk either through a letter of credit or appropriate credit insurance will be followed.

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    No tickers found. You need to add tickers and save as draft before fetching disclosure

    The post Codan (ASX:CDA) share price charges higher on major new contract win appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2Ra2Zad

  • Gold Road (ASX:GOR) share price runs lower on HY20 results

    treasure chest full of gold

    The Gold Road Resources Ltd (ASX: GOR) share price has moved lower after an early trade peak despite the release of positive HY20 results.

    At the time of writing, The Gold Road share price has dropped 0.53% to $151 after an peak of $1.55 in early morning trade. This compares to the S&P/ASX 200 Index (ASX: XJO) which is down 2.1% after a market sell-off in the United States overnight.

    Let’s take a look at the gold miner’s results for the first half of the financial year.

    How did Gold Road perform in FY20?

    For the six-month period ending 30 June, Gold Road produced 131,460 ounces of gold at an all-in sustaining cost of $1,186 per attributable ounce. This was led by its Gruyere Project starting commercial production on 1 October 2019.

    Operating cash flow came in at $59.6 million, up 465% from $12.8 million on the prior year. The increase resulted from gold sales revenue at the Gruyere Project.

    Gold Road sold 60,400 ounces of gold at an average price of $2,237 per ounce, thanks to the rising spot price of gold. This reflected revenue from gold sales of $135.1 million for the first half of the year.

    Earnings before interest, tax, depreciation and amortisation (EBITDA) totalled $61 million compared with a $23 million loss on the prior year.

    Consolidated net profit after tax was $23.4 million vs a $16.9 million loss in HY19.

    The mid-tier gold miner recorded a strong balance sheet with cash on hand $73 million, and debt free after paying $25 million of borrowings on 21 July 2020.

    What did management say?

    Managing director and CEO Duncan Gibbs was pleased with Gold Road’s result. He said:

    June saw us celebrate our first year of gold production at Gruyere… We are seeing some positive signs in terms of throughput and recoveries, but we are still on the journey of improving plant availability as we continue to transition into fresh rock. The strong cash flow performance at Gruyere has enabled us to pay down all our debt within less than 10 months from declaring commercial production and this leaves us in a very strong position.

    Mr Gibbs went on to say the company was continuing an exploration push in the underexplored Yamarna Greenstone Belt.

    The half year saw us realign strategy to increase the likelihood of us making meaningful discoveries, as befits a company of our size. The relatively shallow aircore drilling completed so far this year will lead to deeper bedrock drilling of new targets over the coming 6 to 12 months.

    About the Gold Road share price

    The Gold Road share price has risen 190% since falling to its 52-week low of 80.5 cents in March. From reaching an all-time high of $2.02 achieved in July, the Gold Road share price is up 11% since the start of the calendar year.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Gold Road (ASX:GOR) share price runs lower on HY20 results appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/32b6fbx

  • Why the PointsBet (ASX:PBH) share price tumbled 21% lower today

    basketball player jumping high to take a shot for goal

    The PointsBet Holdings Ltd (ASX: PBH) share price is back from its trading halt and is dropping lower on Wednesday.

    At one stage the sports betting company’s shares were down as much as 21.5% to $10.73.

    They have since recovered a touch but are still down 14% to $11.80 at the time of writing.

    Despite this decline, PointsBet’s shares are still up a massive 275% since the start of the year.

    Why is the PointsBet share price crashing lower?

    This morning PointsBet returned from its trading halt following the successful completion of the institutional component of its fully underwritten 1 for 6.5 pro rata accelerated renounceable entitlement offer.

    According to the release, the institutional entitlement offer closed on Tuesday and raised gross proceeds of approximately $70.5 million. Approximately 55% of eligible entitlements were taken up by existing shareholders, with the remainder snapped up following a bookbuild of shortfall shares.

    The latter attracted strong demand from both existing and new institutional, professional, and sophisticated investors. So much so, the final clearing price under the institutional shortfall bookbuild was $12.50, which represents a premium of $6.00 to the entitlement offer price of $6.50 per share.

    PointsBet will now push ahead with the retail component of the entitlement offer and expects to raise approximately $82.7 million.

    Combined with its already completed $200 million institutional placement, this will bring the total raised to approximately $353 million.

    Why is PointsBet raising funds?

    The company is raising these funds largely to support its US marketing activities over the coming years.

    PointsBet recently announced a major agreement with NBC Universal which includes a committed marketing spend of US$393.1 million over five years.

    Management also plans to use the funds for technology and platform development and US business development. The latter includes market access and government licensing fees and sportsbook fit-out costs.

    These 3 stocks could be the next big movers in 2020

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Pointsbet Holdings Ltd. The Motley Fool Australia has recommended Pointsbet Holdings Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Why the PointsBet (ASX:PBH) share price tumbled 21% lower today appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3jZVwGW

  • No savings at 50? I think these tips can help you retire early with stocks

    Wooden arrow sign stating 'retirement' against backdrop of beach

    Buying cheap stocks today to retire early may not seem to be a sound strategy at first glance. After all, a second stock market crash could be ahead due to a weak global economic outlook, as well as the risk of a further rise in coronavirus cases.

    However, investing in a wide range of high-quality businesses today for the long run could enable you to benefit from the stock market’s recovery potential.

    Over time, this may help you to build a surprisingly large nest egg, even from a standing start at age 50, that provides you with a generous passive income in older age.

    Retire early with a long-term focus

    Building a nest egg that enables you to retire early will take a considerable amount of time. However, at age 50, you are likely to have sufficient time to do so. After all, you are likely to have at least a decade or more through which to use the stock market’s growth potential to build a retirement portfolio. As such, even if stock prices come under further pressure in the coming months, there is likely to be enough time for them to recover in time to boost the prospect of bringing forward your retirement date.

    A long-term focus will allow you to take advantage of favourable buying opportunities at the present time. The recent market crash has caused a number of stocks to trade at cheap prices. While they may move lower in the short run, they could provide long-term investors with the opportunity to buy bargain stocks that offer turnaround potential. Over time, they may produce higher returns than the wider market’s long-term average, and could have a positive impact on your retirement plans.

    A diverse range of quality stocks

    Of course, economic uncertainty means that not all stocks will help you to retire early. There may be some sectors and/or businesses that are unable to deliver strong profit growth – especially since the outlook for many industries is currently very uncertain amidst a period of weak economic performance.

    Therefore, it is logical to buy a diverse range of businesses within your portfolio. This can reduce your reliance on a small number of companies, while also providing exposure to a wider range of sectors that may boost your portfolio’s return profile.

    Furthermore, buying high-quality stocks may help you to retire early. Companies with wide economic moats, sound finances and clear growth strategies may be better able to strengthen their market positions in the aftermath of the market crash, and deliver improving profitability that leads to a rising stock price. Over time, they may outperform the stock market and make a large positive contribution to your portfolio’s performance, thereby allowing you to bring forward your retirement date.

    Legendary stock picker names 5 cheap stocks to buy right now

    Motley Fool resident tech stock expert Dr. Anirban Mahanti has stumbled upon five stocks he believes could be some of the greatest discoveries of his investing career.

    These little-known ASX stocks are growing like gangbusters, yet you can buy them today for less than $5 a share. Click here to learn more.

    See these 5 cheap stocks

    More reading

    Motley Fool contributor Peter Stephens has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post No savings at 50? I think these tips can help you retire early with stocks appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3k36MCH